272 related articles for article (PubMed ID: 37141250)
1. The regulatory network of the chemokine CCL5 in colorectal cancer.
Zhang XF; Zhang XL; Wang YJ; Fang Y; Li ML; Liu XY; Luo HY; Tian Y
Ann Med; 2023 Dec; 55(1):2205168. PubMed ID: 37141250
[TBL] [Abstract][Full Text] [Related]
2. Tumor bud-derived CCL5 recruits fibroblasts and promotes colorectal cancer progression via CCR5-SLC25A24 signaling.
Gao LF; Zhong Y; Long T; Wang X; Zhu JX; Wang XY; Hu ZY; Li ZG
J Exp Clin Cancer Res; 2022 Mar; 41(1):81. PubMed ID: 35241150
[TBL] [Abstract][Full Text] [Related]
3. A promising research direction for colorectal cancer immunotherapy: The regulatory mechanism of CCL5 in colorectal cancer.
Li Y; Lei Y; Sun J; Zhang W; Li X; Chen S; Kong D; Chen C; Bi K; Luo X; Wang H; Li B; Luo H; Xu Y
Front Oncol; 2022; 12():1020400. PubMed ID: 36387070
[TBL] [Abstract][Full Text] [Related]
4. Anti-VEGFR2-Interferon α Promotes the Infiltration of CD8+ T Cells in Colorectal Cancer by Upregulating the Expression of CCL5.
Huang L; Gao R; Nan L; Qi J; Yang S; Shao S; Xie J; Pan M; Qiu T; Zhang J
J Immunother; 2024 Jul-Aug 01; 47(6):195-204. PubMed ID: 38654631
[TBL] [Abstract][Full Text] [Related]
5. CCL5-deficiency enhances intratumoral infiltration of CD8
Zhang S; Zhong M; Wang C; Xu Y; Gao WQ; Zhang Y
Cell Death Dis; 2018 Jul; 9(7):766. PubMed ID: 29991744
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophage-derived chemokine CCL5 facilitates the progression and immunosuppressive tumor microenvironment of clear cell renal cell carcinoma.
Xu W; Wu Y; Liu W; Anwaier A; Tian X; Su J; Huang H; Wei G; Qu Y; Zhang H; Ye D
Int J Biol Sci; 2022; 18(13):4884-4900. PubMed ID: 35982911
[No Abstract] [Full Text] [Related]
7. Human MSCs promotes colorectal cancer epithelial-mesenchymal transition and progression via CCL5/β-catenin/Slug pathway.
Chen K; Liu Q; Tsang LL; Ye Q; Chan HC; Sun Y; Jiang X
Cell Death Dis; 2017 May; 8(5):e2819. PubMed ID: 28542126
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer.
Aldinucci D; Casagrande N
Int J Mol Sci; 2018 May; 19(5):. PubMed ID: 29772686
[TBL] [Abstract][Full Text] [Related]
9. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
[TBL] [Abstract][Full Text] [Related]
10. Alcohol consumption promotes colorectal carcinoma metastasis via a CCL5-induced and AMPK-pathway-mediated activation of autophagy.
Zhao H; Chen D; Cao R; Wang S; Yu D; Liu Y; Jiang Y; Xu M; Luo J; Wang S
Sci Rep; 2018 Jun; 8(1):8640. PubMed ID: 29872080
[TBL] [Abstract][Full Text] [Related]
11. The inflammatory chemokine CCL5 and cancer progression.
Aldinucci D; Colombatti A
Mediators Inflamm; 2014; 2014():292376. PubMed ID: 24523569
[TBL] [Abstract][Full Text] [Related]
12. Macrophage-derived CCL5 facilitates immune escape of colorectal cancer cells via the p65/STAT3-CSN5-PD-L1 pathway.
Liu C; Yao Z; Wang J; Zhang W; Yang Y; Zhang Y; Qu X; Zhu Y; Zou J; Peng S; Zhao Y; Zhao S; He B; Mi Q; Liu X; Zhang X; Du Q
Cell Death Differ; 2020 Jun; 27(6):1765-1781. PubMed ID: 31802034
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel biomarker-CCL5 using antibody microarray for colorectal cancer.
Chen M; Yang X; Yang M; Zhang W; Li L; Sun Q
Pathol Res Pract; 2019 May; 215(5):1033-1037. PubMed ID: 30871911
[TBL] [Abstract][Full Text] [Related]
14. CCL5 production in lung cancer cells leads to an altered immune microenvironment and promotes tumor development.
Melese ES; Franks E; Cederberg RA; Harbourne BT; Shi R; Wadsworth BJ; Collier JL; Halvorsen EC; Johnson F; Luu J; Oh MH; Lam V; Krystal G; Hoover SB; Raffeld M; Simpson RM; Unni AM; Lam WL; Lam S; Abraham N; Bennewith KL; Lockwood WW
Oncoimmunology; 2022; 11(1):2010905. PubMed ID: 35481284
[TBL] [Abstract][Full Text] [Related]
15. Cytokine- and chemokine-induced inflammatory colorectal tumor microenvironment: Emerging avenue for targeted therapy.
Bhat AA; Nisar S; Singh M; Ashraf B; Masoodi T; Prasad CP; Sharma A; Maacha S; Karedath T; Hashem S; Yasin SB; Bagga P; Reddy R; Frennaux MP; Uddin S; Dhawan P; Haris M; Macha MA
Cancer Commun (Lond); 2022 Aug; 42(8):689-715. PubMed ID: 35791509
[TBL] [Abstract][Full Text] [Related]
16. Bone marrow-derived mesenchymal stem cells promote colorectal cancer progression via CCR5.
Nishikawa G; Kawada K; Nakagawa J; Toda K; Ogawa R; Inamoto S; Mizuno R; Itatani Y; Sakai Y
Cell Death Dis; 2019 Mar; 10(4):264. PubMed ID: 30890699
[TBL] [Abstract][Full Text] [Related]
17. C-C chemokine hepatocellular carcinoma motif ligand 5-deficiency promotes hepatocellular carcinoma progression by affecting B cell recruitment.
Li X; Han QC; Yu C; Luo YC; Wang F; Sun XH; Gao YQ; Tan WF; Xia Q
J Dig Dis; 2021 Jul; 22(7):433-441. PubMed ID: 33978316
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Silveira MJ; Castro F; Oliveira MJ; Sarmento B
Biomater Sci; 2021 May; 9(9):3228-3243. PubMed ID: 33949441
[TBL] [Abstract][Full Text] [Related]
19. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy.
Mao Q; Min J; Zeng R; Liu H; Li H; Zhang C; Zheng A; Lin J; Liu X; Wu M
Theranostics; 2022; 12(14):6088-6105. PubMed ID: 36168633
[TBL] [Abstract][Full Text] [Related]
20. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
Yue Y; Zhang Q; Sun Z
Front Immunol; 2021; 12():758040. PubMed ID: 35140706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
